Our focus is to understand the mechanisms that allow zoonotic, sylvatic arthropod-borne viruses to jump species boundaries and cause disease. Shared lab account
Galveston, TX
Joined October 2019
- Tweets932
- Following325
- Followers1.5K
- Likes1.1K
Nikos Vasilakis retweeted
Achieving the rank of professor is a crowning achievement of a career in academia. In FY26, UTMB appointed or promoted 17 new professors, and we had the pleasure of celebrating with many of them at last night's Professors' Dinner. Congratulations to all our new professors!
Nikos Vasilakis retweeted
NIAID has awarded $17.9M to re-establish the Centers for Research in Emerging Infectious Diseases Network (CREID) program with the highest possible standards for biosafety and biosecurity to protect the public.
Learn more:
Nikos Vasilakis retweeted
Dr. Scott Weaver’s distinguished career has helped shape the modern understanding of emerging infectious diseases while establishing UTMB as a global leader in this realm.
He will receive the UTMB Lifetime Achievement in Research Award on 9/10! Info: utmb.us/g9v
Nikos Vasilakis retweeted
Today marks a defining moment for @UTMBHealth and the future of cardiovascular medicine. The Sealy & Smith Foundation has committed $180 million to advance the Sealy Heart & Vascular Institute. This is the largest philanthropic gift in UTMB history and among the largest ever made to a cardiovascular institute at an academic medical center in the United States. 🙏
Let’s get to work and save lives.
@docHJ @utsystem
Nikos Vasilakis retweeted
Conducting real-time epidemiological research during a pandemic demands adaptability. In the AVISA study, we faced recruitment challenges, vaccination shifts, and logistical complexity. Progress relied on flexibility and coordination. resilient research requires rapid adaptation.
Nikos Vasilakis retweeted
In a disruptive environment, delay is the highest-risk strategy. Don’t wait for full clarity.
Another mistake is treating AI, workforce, and strategy as separate conversations. They are one and the same transformation.
Nikos Vasilakis retweeted
Congratulations to Dr. Shannan L. Rossi on being named the inaugural Associate Dean of Strategic Initiatives, @UTMBGSBS! We are grateful for her leadership as she helps advance the school’s strategic priorities and strengthen the impact of its academic and research programs.
Nikos Vasilakis retweeted
Our new study presents an integrated pipeline for rapid epitope-based pan-alphavirus vaccine design, combining immunoinformatics, structural modeling, and experimental validation to identify broadly immunogenic candidates.
Congratulations to Alice and the entire team @afversiani
Nikos Vasilakis retweeted
We report in Nature Medicine that the single-dose Butantan dengue vaccine showed 65% efficacy against symptomatic dengue and 80.5% protection against severe disease over 5 years, with a favorable safety profile in participants aged 2–59 in Brazil.
Αn important study long overdue!
What a great day for the Houston Marathon. Great community of supporters, lots of fun and a nice cold weather. Congratulations to all runners! @utmbhealth @ASTMH @Rossi_viruslab
Great collaborative work. Congratulations to all team members for th hard work!
Intra-host population dynamics of chikungunya virus in humans and naturally infected Aedes mosquitoes reveal transmission-driven diversity academic.oup.com/ve/article/…
just published!
@ACAV_ASTMH @AgenciaFAPESP @famerp @Vasilakis_Lab
Standardization of Quantitative Plaque-Based Viral Assays for Orthoflavivirus Cacipacoré
✍ by Saivish et al.
➡️ mdpi.com/1999-4915/17/10/135…
Nikos Vasilakis retweeted
Excellent seminar and motivational talk with Carla Saleh, her love for science radiates from her.
@SalehLabParis
a monumental effort led by Peter Simmonds & Jens Kuhn to reorganize the Family Flaviviridae based on analysis of RNA-directed RNA polymerase (RdRP) hallmark gene sequences is finally out. Enjoy reading! #ICTV, @ASTMH @utmbhealth @sbviro @
Delighted to see Marielena's manuscript on the "Standardization of Quantitative Plaque-Based Viral Assays for Orthoflavivirus Cacipacoré" published. A collaborative effort with colleagues on our drive to characterize a number of Brazilian neglected orthoflaviviruses.
We Look forward welcoming you on October 14th for Prof. Kim's webinar "Development of Vaccines Against Alphaviruses and Flaviviruses". Register: zoomgov.com/webinar/register…. @create_neo @ASTMH @ACAV_ASTMH @sbviro @Virology_FAMERP @Rossi_viruslab
Nikos Vasilakis retweeted
A new ms is out!
Clinical and laboratory profiles of Oropouche virus disease from the 2024 outbreak in Manaus, Brazilian Amazon
Nice work with our friends from Fundacao Medicina Tropical Manaus
journals.plos.org/plosntds/a…
Nikos Vasilakis retweeted
Time to Re-think Strategies—And Refocus on Team Skills
I’ll explore how to make that shift in the unique context of academic healthcare during my upcoming C-Suite Assembly talk.
It’s time to build organizations where collaboration, adaptability, and shared purpose drive performance and innovation.
